课题基金 / 基金详情

Understanding and exploiting regulation in pathogenic enteroaggregative Escherichia coli

Understanding and exploiting regulation in pathogenic enteroaggregative Escherichia coli
了解和利用致病性肠聚集性大肠杆菌的调控
批准号:
BB/R017689/1
负责人:
Steve Busby
金额:
$62.43万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Steve Busby的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Many bacteria cause diarrhoea in humans because, when they are ingested, they colonise the lower gut by attaching to the lining of the intestine. They then produce products that cause abnormal levels of fluid build-up in the host's gut. For most people, such diarrhoea is merely an irritation, but, for some, it can be life-threatening. Currently, one especially troublesome cause of diarrhoea, in both developed and developing countries, is enteroaggregative Escherichia coli (EAEC). This harmful organism probably evolved from harmless Escherichia coli strains following the acquisition of a score or so of extra genes that allow it to attach to human intestines and cause diarrhoea. Studies with EAEC and with other harmful bacteria have shown that the expression of these extra genes, which cause disease, is tightly controlled. For EAEC, and related harmful bacteria, we now know what the principal regulators are. Interestingly, the most important of these regulators was acquired with the other extra genes, and its role appears to be mainly to make sure that the harmful bacteria only express the disease-causing genes when the harmful bacteria are in the host. Hence the main aims of the work proposed here are to do experiments that will tell us how the main regulator is activated when the bacteria get to the gut, and how the activity of the regulator is turned on and turned off. We plan to look at EAEC strains from patients from different countries to see if the same mechanism is always used and also to check the harmful genes in the different strains. Once we have understood how the regulator works, we will use genetic engineering techniques to make derivatives of the regulator that are defective and so will interfere with virulent strains. We will devise ways to deliver the defective regulator to harmful cells during infection with a view to developing a new way to treat bactreial infection that involves 'disarming' the harmful bacteria rather than killing them.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1080/21505594.2022.2111754
发表时间: 2022-12
期刊: Virulence
影响因子: 5.2
作者: []
通讯作者:
RNA polymerase spoiled for choice as transcription begins.
当转录开始时,RNA 聚合酶的选择就变多了。
DOI: 10.1073/pnas.2110640118
发表时间: 2021
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Busby SJW]
通讯作者: Busby SJW
DOI: 10.1099/mgen.0.000922
发表时间: 2023-03
期刊: MICROBIAL GENOMICS
影响因子: 3.9
作者: [Browning, Douglas F., Hobman, Jon L., Busby, Stephen J. W.]
通讯作者: Busby, Stephen J. W.
Heterologous Expression of Membrane Proteins in E. coli.
膜蛋白在大肠杆菌中的异源表达。
DOI: 10.1007/978-1-0716-2368-8_4
发表时间: 2022
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Depping P]
通讯作者: Depping P
6
    Global Regulators in a Bacterial Pathogen and Virulence
    • 批准号:
      BB/W00285X/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $70.39万
    • 财政年份:
      2022
    • 负责人:
      Steve Busby
    • 依托单位:
    Bacterial chromosome structure and transcription
    • 批准号:
      BB/J006076/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $66.83万
    • 财政年份:
      2012
    • 负责人:
      Steve Busby
    • 依托单位:
    海外基金